These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21198787)

  • 21. [Hypermethylation of promoter region of RAS association domain family gene1A in esophageal squamous cell carcinoma and significance thereof].
    Cong DG; Wang SF
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2932-4. PubMed ID: 18261310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PTCH promoter methylation at low level in sporadic basal cell carcinoma analysed by three different approaches.
    Heitzer E; Bambach I; Dandachi N; Horn M; Wolf P
    Exp Dermatol; 2010 Oct; 19(10):926-8. PubMed ID: 20849535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Clin Cancer Res; 2003 Apr; 9(4):1441-5. PubMed ID: 12684417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
    Zhang S; Kong WJ
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
    Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
    Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
    Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C; Yin B; Lu Q; Zhou X; Hu J; Yang Y; Yu F; Yuan Y
    Cancer Invest; 2007 Dec; 25(8):685-90. PubMed ID: 18058463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance.
    Chang HW; Chow V; Lam KY; Wei WI; Yuen A
    Cancer; 2002 Jan; 94(2):386-92. PubMed ID: 11900224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution melting analysis of BLU methylation levels in gastric, colorectal, and pancreatic cancers.
    Shao Y; Zhang W; Zhang C; Wu Q; Yang H; Zhang J; Guan M; Wan J; Yu B
    Cancer Invest; 2010 Jul; 28(6):642-8. PubMed ID: 20394502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Value of promoter methylation of RASSF1A, p16, and DAPK genes in induced sputum in diagnosing lung cancers].
    Peng Z; Shan C; Wang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 35(3):247-53. PubMed ID: 20360646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aberrant methylation of Fragile Histidine Triad gene is associated with poor prognosis in early stage esophageal squamous cell carcinoma.
    Lee EJ; Lee BB; Kim JW; Shim YM; Hoseok I; Han J; Cho EY; Park J; Kim DH
    Eur J Cancer; 2006 May; 42(7):972-80. PubMed ID: 16564166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers.
    Kang HC; Kim IJ; Park JH; Shin Y; Park HW; Ku JL; Yang HK; Lee KU; Choe KJ; Park JG
    Oncol Rep; 2004 Jul; 12(1):129-33. PubMed ID: 15201973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
    Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
    Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide profiling of promoter methylation in human.
    Hatada I; Fukasawa M; Kimura M; Morita S; Yamada K; Yoshikawa T; Yamanaka S; Endo C; Sakurada A; Sato M; Kondo T; Horii A; Ushijima T; Sasaki H
    Oncogene; 2006 May; 25(21):3059-64. PubMed ID: 16407832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
    Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypermethylation of the GATA genes in lung cancer.
    Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
    Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of p16 gene mutation, deletion and methylation in patients with arseniasis produced by indoor unventilated-stove coal usage in Guizhou, China.
    Zhang AH; Bin HH; Pan XL; Xi XG
    J Toxicol Environ Health A; 2007 Jun; 70(11):970-5. PubMed ID: 17479413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of expression of a novel cadherin molecule, T-cadherin, in basal cell carcinoma of the skin.
    Takeuchi T; Liang SB; Ohtsuki Y
    Mol Carcinog; 2002 Dec; 35(4):173-9. PubMed ID: 12489108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant hypermethylation of the promoter region of the CHFR gene is rare in primary breast cancer.
    Tokunaga E; Oki E; Nishida K; Koga T; Yoshida R; Ikeda K; Kojima A; Egashira A; Morita M; Kakeji Y; Maehara Y
    Breast Cancer Res Treat; 2006 May; 97(2):199-203. PubMed ID: 16502017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.